EUVIMEDDescobrir EUVIMED
ÜbersichtsarbeitOpen access

Novel Migraine Treatments: A Review

Naveen George, Stewart J Tepper

Journal of Oral and Facial Pain and Headache · 2023

DOI: 10.11607/ofph.3163 ↗

At a glance

Übersichtsarbeit in Journal of Oral and Facial Pain and Headache, 2023. Written by Naveen George and 1 co-authors. Major MEDLINE topics: Migraine Disorders, Drug-Related Side Effects and Adverse Reactions. Cited 6 times so far (Crossref). The full text is freely available in PubMed Central.

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Aims

To present a review of the mechanisms of action, available clinical data, and safety profiles of novel migraine therapeutics to inform practice.

Methods

PubMed, Medline, and Google Scholar were searched for randomized controlled trials (24 publications), review articles (15 publications), and other pertinent literature (16 publications) discussing the novel migraine therapeutics available between the years 2010 and 2021. All publications were reviewed to assess the mechanism of action, relevant clinical data, and side effect profile for each novel treatment. Therapeutic gain was also recorded in studies that included a placebo arm.

Results

A total of 55 studies were included in the final analysis. In the preventive treatment of migraine, novel medications target calcitonin gene-related peptide (CGRP) and fall into either the monoclonal anti-CGRP or gepant class. For the acute treatment of migraine, novel medications fall into either the ditan or gepant class. Several medical devices have been developed for the acute and preventive treatment of migraine.

Conclusion

Novel therapeutics are available for both the prevention and acute treatment of migraine headaches. These new medications and neuromodulatory devices appear overall to be safe and effective in the management of migraine headaches.

Subjects

MeSH terms (MEDLINE)

Migraine DisordersDrug-Related Side Effects and Adverse ReactionsHumansCalcitonin Gene-Related Peptide Receptor AntagonistsCalcitonin Gene-Related PeptideReceptors, Calcitonin Gene-Related Peptide

Substances

Calcitonin Gene-Related Peptide Receptor AntagonistsCalcitonin Gene-Related PeptideReceptors, Calcitonin Gene-Related Peptide

Cite

APA

George, N., & Tepper, S. J. (2023). Novel Migraine Treatments: A Review. Journal of Oral and Facial Pain and Headache. https://doi.org/10.11607/ofph.3163

Vancouver

George N, Tepper SJ. Novel Migraine Treatments: A Review. Journal of Oral and Facial Pain and Headache. 2023. doi:10.11607/ofph.3163

BibTeX
@article{George2023,
  author = {George, Naveen and Tepper, Stewart J},
  title = {Novel Migraine Treatments: A Review},
  journal = {Journal of Oral and Facial Pain and Headache},
  year = {2023},
  doi = {10.11607/ofph.3163}
}
Start for free →